Abiopharma

🔍 Hancock Mark (Director)

Company: PACS Group, Inc. (PACS)

Report Date: 2026-03-24

Detailed Transactions and Holdings:

• Acquired 98,154 shares of Common Stock (Direct)
  Date: 2026-03-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 54,602,597.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026, subject to the Reporting Person's continued service through the applicable vesting date.